Baseline apnoea/hypopnoea index and high-sensitivity C-reactive protein for the risk of recurrence of atrial fibrillation after successful electrical cardioversion: a predictive model based upon the multiple effects of significant variables
Authors:
Open Access
- 14 May 2009
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 11 (7) , 902-909
Abstract
We tested apnoea/hypopnoea index (AHI), high-sensitivity (hs) C-reactive protein and clinical/instrumental variables as predictors of atrial fibrillation (AF) recurrence over 1-year follow-up after successful electrical cardioversion. We enrolled 158 consecutive patients. Apnoea/hypopnoea index was assessed with standard overnight polysomnography and hs-C-reactive protein with immunonephelometry assay the day before electrical cardioversion. Atrial fibrillation recurrences occurred in 81 patients (51%). Predictors at univariate analysis were: AHI ≥ 15 events/h ( P = 0.001), hs-C-reactive protein >0.30 mg/dL ( P = 0.009), AF duration >3 days ( P = 0.008), diabetes ( P = 0.03), and ongoing anti-arrhythmic therapy at the time of electrical cardioversion ( P = 0.03). Survival analysis confirmed that patients with AHI ≥ 15 events/h and hs-C-reactive protein > 0.30 mg/dL had a higher recurrence rate of AF (log rank P = 0.0006 and P = 0.01, respectively). Predictors at multivariate analysis were: AHI ≥ 15 events/h ( P = 0.003), hs-C-reactive protein > 0.30 mg/dL ( P = 0.01) and ongoing anti-arrhythmic therapy ( P = 0.04). A predictive model based upon the multiple effects of significant variables plus age as a continuous variable stratified the risk of AF recurrence, more than tripled with all dichotomized variables altered with respect to normal variables (85 vs. 27%). AHI ≥ 15 events/h and hs-C-reactive protein > 0.30 mg/dL are the strongest predictors of the predictors chosen of AF recurrence after successful electrical cardioversion over 1-year follow-up.Keywords
This publication has 40 references indexed in Scilit:
- Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcomeInternational Journal Of Clinical Practice, 2007
- The Risk Profile for Obstructive Sleep Apnea Does Not Affect the Recurrence of Atrial FibrillationPacing and Clinical Electrophysiology, 2006
- Discordant Regulation of CRP and NT‐proBNP Plasma Levels After Electrical Cardioversion of Persistent Atrial FibrillationPacing and Clinical Electrophysiology, 2006
- High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversionInternational Journal of Cardiology, 2006
- Is atrial fibrillation an inflammatory disorder?European Heart Journal, 2005
- Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillationThe American Journal of Cardiology, 2005
- Obstructive Sleep Apnea and the Recurrence of Atrial FibrillationCirculation, 2003
- Predictors for Maintenance of Sinus Rhythm after Cardioversion in Patients with Nonvalvular Atrial FibrillationEchocardiography, 2002
- Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutterThe American Journal of Cardiology, 1991
- Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndromeThe American Journal of Cardiology, 1983